GAPDH and small cell lung carcinoma: To test this possibility, we treated SCLC cells with the small molecule GAPDH inhibitor koningic acid (KA) and observed a glucose-dependent decrease in ATP levels, a finding consistent with a previous report that KA treatment causes glucose-dependent ATP decreases in susceptible cells12 (Fig. 2h and Supplementary Fig. 2c).